|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61N 1/30 | |
| A61N 1/04 | |||
| A61N 1/18 | |||
| A61N 1/32 | |||
| A61M 37/00 | |||
| A61K 9/00 |
| (11) | Number of the document | 2396073 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10741574.7 |
| Date of filing the European patent application | 2010-02-03 | |
| (97) | Date of publication of the European application | 2011-12-21 |
| (45) | Date of publication and mention of the grant of the patent | 2019-05-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/023112 |
| Date | 2010-02-03 |
| (87) | Number | WO 2010/093546 |
| Date | 2010-08-19 |
| (30) | Number | Date | Country code |
| 537243 | 2009-08-06 | US | |
| 152251 P | 2009-02-12 | US |
| (72) |
IMRAN, Mir, US
|
| (73) |
Incube Labs, LLC,
2051 Ringwood Avenue, San Jose, CA 95131,
US
|
| (54) | IONTOPHORETIC SYSTEM FOR TRANSDERMAL DELIVERY OF ACTIVE AGENTS FOR THERAPEUTIC AND MEDICINAL PURPOSES |
| IONTOPHORETIC SYSTEM FOR TRANSDERMAL DELIVERY OF ACTIVE AGENTS FOR THERAPEUTIC AND MEDICINAL PURPOSES |